Calumet Q2 revenue beats expectations, net loss widens
Overview
Calumet Q2 revenue beats analyst expectations, driven by strong Specialties performance
Net loss widens to $147.9 mln from $39.1 mln in prior year
Adjusted EBITDA with Tax Attributes rises to $76.5 mln, aided by cost savings
Outlook
Calumet expects Montana Renewables SAF production of 120-150 mln gallons by Q2 2026
Result Drivers
COST REDUCTIONS - Achieved $42 mln in year-over-year operating cost savings through first half of 2025
SPECIALTIES PERFORMANCE - Strong sales and margin expansion despite planned turnaround at Shreveport facility
MONTANA RENEWABLES - Record operational performance and reduced operating costs, enhancing competitive position
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $1.03 bln | $925.20 mln (5 Analysts) |
Q2 EPS |
| -$1.7 |
|
Q2 Net Income |
| -$147.90 mln |
|
Q2 Adjusted EBITDA |
| $55.10 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the oil & gas refining and marketing peer group is "buy"
Wall Street's median 12-month price target for Calumet Inc is $17.00, about 12.3% above its August 7 closing price of $14.91
Press Release: ID:nPn2sNgSza
